Friday, January 24 12:53:30
BioMarin, a US pharmaceutical company which invested $50m (E37m) to create 100 jobs at Ringaskiddy in Co Cork, said today that it is to hire another 40 people.
The Cork site will manufacture products to treat rare genetic diseases and the move to hire new staff comes before the plant goes into production.
BioMarin says there is potential to create many more jobs at the Cork plant.
PharmaChemical Ireland, the Ibec group that represents the pharmaceutical and chemical sector, welcomed the launch by the global biotech company of the next phase of its investment at its manufacturing operations in Ringaskiddy.
PharmaChemical Ireland Director Matt Moran said: "This investment is further evidence that the sector here is continuing to transform and grow. We continue to attract quality investment and the prospects for the industry in Ireland look good. However, other countries are competing aggressively and we need to stay ahead. Ensuring that Ireland remains an attractive investment location must remain a top priority for government."
Over 25,000 people are employed in the Irish pharmaceutical and chemical sector, 46pc of which are third-level graduates; these jobs support a further 25000 indirect jobs in the economy. Eight of the top 10 global pharmaceutical and chemical companies have operations in Ireland.